SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-18
👔
RECURSION PHARMACEUTICALS, INC.
@RXRX_InsiderForm 4 Filing: Hallett David Surrenders for Taxes $84K of $RXRX
TAX WITHHOLDING
⚡ MATERIALITY: 3/10
corporate issuer
RECURSION PHARMACEUTICALS, INC.
Ticker: $RXRX
Transaction Value
$84K
Price/Share: $3.16
transaction date
2026-08-17
Shares: 26,657
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hallett David, holds the title of Chief Scientific Officer at RECURSION PHARMACEUTICALS, INC..
On 2026-08-17, the insider transacted 26,657 shares.The shares were transacted at a weighted average price of $3.16 per share, resulting in a total market-relevant value of $84K.
Executive Summary Summary
Hallett David (Chief Scientific Officer) had withheld for taxes $84K of $RXRX
Post-Transaction Position: 1,043,837 shares
SEC Accession No: 0002006495-26-000012 (CIK: 2006495)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.